Closing the Generation Gap: Part 2 - Hemophilia Federation of America

Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->

Prophylaxis and hemophilia care in LATAM: Baring it all—Highlights from the CLAHT 2021 symposium - DiMinno - 2022 - eJHaem - Wiley Online Library

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Ukraine One-Year Report

Diagnostics, Free Full-Text

Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India: Molecular Therapy

Housing Market: Biden Wants to Fix Eviction Crisis, Spiraling Home Prices - Bloomberg

Core Concepts - HIV in Infants and Children - Key Populations - National HIV Curriculum

Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study - Research and Practice in Thrombosis and Haemostasis

Closing the Medicare Part D Coverage Gap: Trends, Recent Changes, and What's Ahead

Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences - Journal of Pharmaceutical Sciences